Literature DB >> 20380937

Fatigue-type stress fractures of the lower limb associated with fibrous cortical defects/non-ossifying fibromas in the skeletally immature.

A Shimal1, A M Davies, S L J James, R J Grimer.   

Abstract

AIM: To investigate the association of a fatigue-type stress fracture and a fibrous cortical defect/non-ossifying fibroma (FCD/NOF) of the lower limb long bones in skeletally immature patients.
MATERIALS AND METHODS: The patient database of a specialist orthopaedic oncology centre was searched to determine the number of skeletally immature patients (<or=16 years of age) over an 18 year period with a lower limb long bone lesion ultimately shown to be a fatigue-type stress fracture. The diagnosis was established by a combination of typical imaging findings of a fatigue-type stress fracture, the absence of aggressive features suggestive of a sarcoma (e.g., interrupted periosteal reaction, cortical breach, and a soft-tissue mass) together with evidence of consolidation or healing on follow-up radiographs and resolution of symptoms over the subsequent weeks. The database was also used to determine the number of skeletally immature cases (<or=16 years of age) referred in the same period in which the principal lesion was shown to be a fibrous cortical defect (FCD) or non-ossifying fibroma (NOF) of the lower limb long bones. The clinical and imaging features of those cases common to both groups (i.e., with both a fatigue-type stress fracture and a FCD or NOF) were reviewed.
RESULTS: Six percent of patients (five cases) referred to an orthopaedic oncology unit, who were subsequently shown to have a stress fracture of the lower limb long bones, were found to have a related FCD/NOF. All had been referred with a suggested diagnosis of a bone sarcoma and/or osteomyelitis. The possibility of a stress fracture had been raised in only one case. Four cases involved the proximal tibia and one the distal femur. Radiographs revealed that both lesions arose in the posteromedial cortex in all but one of the cases. The radiographs and magnetic resonance imaging (MRI) features were considered typical of the overlapping pathological features of the lesions.
CONCLUSIONS: A sarcoma could be effectively excluded in the absence of true cortical destruction and soft-tissue extension. Both fatigue-type stress fractures and FCD/NOFs occur at similar sites in the long bones. It is postulated that the existence of the latter may cause localized weakening of the bone thereby predisposing to the development of a stress fracture. The co-existence of these two conditions in the skeletally immature should be recognized as the dual pathological processes may contribute to radiological misdiagnosis.

Entities:  

Mesh:

Year:  2010        PMID: 20380937     DOI: 10.1016/j.crad.2010.01.014

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  5 in total

Review 1.  Femoral diaphyseal stress fracture as the initial presentation of acute leukaemia in an adolescent.

Authors:  Helen Emily Chase; Joe Hwong Pang; Anish Pradip Sanghrajka
Journal:  BMJ Case Rep       Date:  2016-06-28

2.  Surgical treatment for symptomatic non-ossifying fibromas of the lower extremity with calcium sulfate grafts in skeletally immature patients.

Authors:  Antonio Andreacchio; Flavia Alberghina; Gianluca Testa; Federico Canavese
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-08-17

3.  CLINICAL REASONING IN THE FACE OF UNCERTAINTY: CONSERVATIVE PHYSICAL THERAPY MANAGEMENT OF A TEENAGE ATHLETE DIAGNOSED WITH A PROXIMAL HUMERAL NON-OSSIFYING FIBROMA.

Authors:  Timothy J Reynolds; Joseph Paul Coviello; Michael Costello
Journal:  Int J Sports Phys Ther       Date:  2018-12

4.  Pathological fractures in children.

Authors:  C B R De Mattos; O Binitie; J P Dormans
Journal:  Bone Joint Res       Date:  2012-10-01       Impact factor: 5.853

5.  A Non-ossifying Fibroma and a Stress Fracture of the Femur Mimicking Bone Malignancy in a Child.

Authors:  Svetoslav A Slavchev; Georgi P Georgiev
Journal:  Cureus       Date:  2020-04-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.